Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

@xconomy.com 4 years ago

Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits

@xconomy.com 4 years ago

Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D

@xconomy.com 4 years ago

Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?

@xconomy.com 5 years ago

Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More

@xconomy.com 5 years ago

Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms

@xconomy.com 5 years ago

Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More